Gemcitabine for advanced endometrial cancer: A retrospective study of the memorial sloan-kettering cancer center experience
Adenocarcinoma, Clear Cell
Neoplasm Recurrence, Local
In a mixed population of patients with previously treated advanced endometrial cancer, gemcitabine was well tolerated and showed modest activity. Patients with clear cell histology appeared to have greater likelihood of benefit.